Navigation Links
Inovio Pharmaceuticals' Market-Leading Intellectual Property Recognized by MDB Capital Award
Date:5/12/2011

BLUE BELL, Pa., May 12, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that MDB Capital Group has recognized Inovio with its CLARUS Award, given annually to publicly traded companies possessing market-changing intellectually property (IP) assets. The award was presented at the second annual Bright Lights Conference in New York City, a meeting that provides institutional investors with a venue to discover the largely unrecognized value of intellectual property.

Christopher A. Marlett, CEO of MDB Capital Group, said, "Inovio Pharmaceuticals was the top company in its industry with the highest 'Tech Score' and number of patent grants, and we are honored to recognize their achievements in driving IP as an asset class and the impact they are making on innovation in America."

MDB's "Tech Score" measures the industry impact of a company's patents, as it is an indicator of a company's competitive position. It is based upon an analysis of the citation ratios of a company's patents relative to its peer group.

Inovio's DNA vaccine pipeline and proprietary delivery technology were selected from MDB's 2011 group of "Best and Brightest" small-cap companies, a group that is advancing some of today's most innovative and market-leading intellectual property. Inovio is one of 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by MDB.

Dr. J. Joseph Kim, Inovio's president and CEO, said: "Intellectual property is the lifeblood of medical innovation and Inovio is proud to be recognized for its preeminent patent estate for our pipeline of DNA vaccines and our innovative vaccine delivery technology."  

Ab
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals to Present at Investor Conferences
2. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
3. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
4. Inovio Pharmaceuticals to Present at Scientific Conferences
5. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
6. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
7. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
8. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
9. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
10. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
11. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
(Date:9/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming Rodman & Renshaw 17 th Annual Global ... New York City .  Dr. Michael ... overview on September 9, 2015. Presentation ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... 2011 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... EST on Friday, January 6, 2012 at the Millennium Hotel, ... Executive Officer, Patrick G. LePore, and other members of the ... growth strategy, current products and pipelines, and business outlook to ...
... Calif., Dec. 5, 2011  Beyond Lucid Technologies, Inc., ... disaster management, and First Response industries, today announced ... the mHealth Summit, and the publication of a ... connect ambulances with hospitals via telemedicine. ...
Cached Medicine Technology:Beyond Lucid Technologies Advances Telemedicine for EMS Providers 2Beyond Lucid Technologies Advances Telemedicine for EMS Providers 3
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed ... Paz. , Schmidt National Law Group, a leading firm in mass-tort litigation, has ... Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary ... waste handling rules constantly evolving in the consumer goods industry, it can be ...
(Date:9/4/2015)... ... , ... “Getting away from the daily stressors and distractions of life may ... ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort Maui at ... Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, has ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at the ... Speakers at the 2015 symposium are doctors and researchers at the top of ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... when added to existing meds, study finds , , ... helps relieve neuropathic pain in people with HIV, ... of Medicine study. , It included 28 HIV ... by opiates or other pain relievers. The researchers ...
... Increases 2008 Net Sales Projections; Affirms Top End of Adjusted* ... Earnings Guidance --, ... global specialty pharmaceutical and medication,delivery company, today reported results for the second quarter ... during the second quarter of 2008, compared to $869.3 ...
... Inclusion for Key, Emerging Biologic Agents That Will Launch ... Years, According to a ... 6 Decision Resources, one of the,world,s leading research ... 89 percent of surveyed rheumatologists,anticipate prescribing Roche/Chugai,s Actemra, following ...
... Aduromed Begins Next Step in Corporate Evolution, Restructuring the Company ... and Augmenting its Board and Management Team, ... Board: ADRM) a leading manufacturer of medical waste,treatment systems, today ... raise of $3.8 million of new equity capital. As,part of ...
... Software, Inc. today,announced the worldwide launch of iFastrack, ... software for reducing business,risk by tracking insurance certificates ... to manage their risk from,uninsured contractors, vendors or ... proof of insurance at the onset of a ...
... Increase Revenues by Up to $2 Million This ... Corporation (OTC,Bulletin Board: BDRR), a medical imaging and ... Imaging, Inc. has entered into,a joint venture (JV) ... Basic Solutions, Inc. will offer mobile cardiac stress ...
Cached Medicine News:Health News:Medicinal Marijuana Eases Neuropathic Pain in HIV 2Health News:Hospira Reports Second-Quarter 2008 Results 2Health News:Hospira Reports Second-Quarter 2008 Results 3Health News:Hospira Reports Second-Quarter 2008 Results 4Health News:Hospira Reports Second-Quarter 2008 Results 5Health News:Hospira Reports Second-Quarter 2008 Results 6Health News:Hospira Reports Second-Quarter 2008 Results 7Health News:Hospira Reports Second-Quarter 2008 Results 8Health News:Hospira Reports Second-Quarter 2008 Results 9Health News:Hospira Reports Second-Quarter 2008 Results 10Health News:Hospira Reports Second-Quarter 2008 Results 11Health News:Hospira Reports Second-Quarter 2008 Results 12Health News:Hospira Reports Second-Quarter 2008 Results 13Health News:Hospira Reports Second-Quarter 2008 Results 14Health News:Hospira Reports Second-Quarter 2008 Results 15Health News:Hospira Reports Second-Quarter 2008 Results 16Health News:Hospira Reports Second-Quarter 2008 Results 17Health News:Hospira Reports Second-Quarter 2008 Results 18Health News:Hospira Reports Second-Quarter 2008 Results 19Health News:Hospira Reports Second-Quarter 2008 Results 20Health News:Hospira Reports Second-Quarter 2008 Results 21Health News:Hospira Reports Second-Quarter 2008 Results 22Health News:Hospira Reports Second-Quarter 2008 Results 23Health News:Hospira Reports Second-Quarter 2008 Results 24Health News:Hospira Reports Second-Quarter 2008 Results 25Health News:Hospira Reports Second-Quarter 2008 Results 26Health News:Hospira Reports Second-Quarter 2008 Results 27Health News:Hospira Reports Second-Quarter 2008 Results 28Health News:Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis 2Health News:Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis 3Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 2Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 3Health News:GG-One Software Announces iFastrack to Help Avoid Insurance Disasters 2Health News:Bederra Corp.'s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions 2
... with Tim™ (Total imaging matrix) technology ... and highest resolution at 3T. With ... advanced applications can now be translated ... with Tim is an excellent dual-purpose ...
... Medical Billing Assistant (MBA) is ... billing and practice management software ... Microsoft SQL Server technology and ... capabilities and account receivable management, ...
... with a practice management system. DAQbilling files ... paper. Your patient statements can also be printed ... combined traditional software and billing services into one ... from anywhere - multiples offices or home. ...
... incorporate 3 mirrors angled at 76°, 66° and ... chamber as well as central and peripheral fundus ... are accurately angled and spaced 120° apart to ... central portion of the lens also provides direct ...
Medicine Products: